A randomised, double-blind, controlled efficacy trial of the LiESP/QA-21 vaccine in naïve dogs exposed to two leishmania infantum transmission seasons.
about
Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral LeishmaniasisRecombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.Field Evaluation of Two Different Treatment Approaches and Their Ability to Control Fleas and Prevent Canine Leishmaniosis in a Highly Endemic AreaImmunogenicity in dogs and protection against visceral leishmaniasis induced by a 14kDa Leishmania infantum recombinant polypeptide.F1 Domain of the Leishmania (Leishmania) donovani Nucleoside Hydrolase Promotes a Th1 Response in Leishmania (Leishmania) infantum Cured Patients and in Asymptomatic Individuals Living in an Endemic Area of Leishmaniasis.Management, prevention and treatment of canine leishmaniosis in north-eastern Spain: an online questionnaire-based survey in the province of Girona with special emphasis on new preventive methods (CaniLeish vaccine and domperidone).Efficacies of prevention and control measures applied during an outbreak in Southwest Madrid, Spain.Hematological, Biochemical, and Serological Findings in Healthy Canine Blood Donors after the Administration of CaniLeish® Vaccine.Scientific Opinion on canine leishmaniosisEvaluation of fluorimetry and direct visualization to interpret results of a loop-mediated isothermal amplification kit to detect Leishmania DNA.Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial.NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis.Canine Leishmaniasis: An Overview of the Current Status and Strategies for Control.Peptide Vaccines for Leishmaniasis.
P2860
Q28551736-9265A567-9915-4C92-A7A4-213509531D91Q36028999-EEA3A42C-6FC6-4462-960A-ACAF96DA7237Q36134667-57BC39A0-34D9-4E54-8FF6-8C4CC2346EC4Q36340603-50376B8F-9509-49BE-8138-75C31505F227Q38658902-0A7505EF-D5A7-480A-897F-672B08D3099DQ39147314-B62D035F-D8A8-4DA7-908F-B3C35B303F6AQ42701650-EF6E5F47-489A-4D06-A64B-342C049B4399Q42741334-7F9417E5-21B3-45D2-9084-074D5DDE1CDFQ47156873-B8EA2DEB-A465-4326-A4D6-FD352DF6C4D4Q52318819-7E4C22D2-0449-4E74-9AC9-BCD0DB289DDAQ53080229-D6FC324C-EF55-435E-923C-ECC402BC4602Q54968645-C3F423C5-3773-401E-A6F4-66A7A6D35420Q55092035-66E40D0C-B199-466A-89B8-67EED280232BQ55210484-B05BE1E4-6E17-4017-967C-571DBEA90115
P2860
A randomised, double-blind, controlled efficacy trial of the LiESP/QA-21 vaccine in naïve dogs exposed to two leishmania infantum transmission seasons.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A randomised, double-blind, co ...... infantum transmission seasons.
@ast
A randomised, double-blind, co ...... infantum transmission seasons.
@en
A randomised, double-blind, co ...... infantum transmission seasons.
@nl
type
label
A randomised, double-blind, co ...... infantum transmission seasons.
@ast
A randomised, double-blind, co ...... infantum transmission seasons.
@en
A randomised, double-blind, co ...... infantum transmission seasons.
@nl
prefLabel
A randomised, double-blind, co ...... infantum transmission seasons.
@ast
A randomised, double-blind, co ...... infantum transmission seasons.
@en
A randomised, double-blind, co ...... infantum transmission seasons.
@nl
P2093
P2860
P1476
A randomised, double-blind, co ...... infantum transmission seasons.
@en
P2093
Aldo Scalone
Anne-Marie Cuisinier
Carmen Cañavate
Carmen Chicharro
David McGahie
Eleonora Fiorentino
Gaetano Oliva
Javier Nieto
Laurie Guegand
Luigi Gradoni
P2860
P356
10.1371/JOURNAL.PNTD.0003213
P407
P577
2014-10-09T00:00:00Z